vs

Side-by-side financial comparison of Strive, Inc. (ASST) and Chime Financial, Inc. (CHYM). Click either name above to swap in a different company.

Chime Financial, Inc. is the larger business by last-quarter revenue ($543.5M vs $255.0K, roughly 2131.4× Strive, Inc.). Chime Financial, Inc. runs the higher net margin — -10.1% vs -75406.7%, a 75396.6% gap on every dollar of revenue. On growth, Chime Financial, Inc. posted the faster year-over-year revenue change (28.8% vs -74.1%).

Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

ASST vs CHYM — Head-to-Head

Bigger by revenue
CHYM
CHYM
2131.4× larger
CHYM
$543.5M
$255.0K
ASST
Growing faster (revenue YoY)
CHYM
CHYM
+102.9% gap
CHYM
28.8%
-74.1%
ASST
Higher net margin
CHYM
CHYM
75396.6% more per $
CHYM
-10.1%
-75406.7%
ASST

Income Statement — Q3 2025 vs Q3 2025

Metric
ASST
ASST
CHYM
CHYM
Revenue
$255.0K
$543.5M
Net Profit
$-192.3M
$-54.7M
Gross Margin
87.2%
Operating Margin
-17288.6%
-11.9%
Net Margin
-75406.7%
-10.1%
Revenue YoY
-74.1%
28.8%
Net Profit YoY
-2726.9%
-148.4%
EPS (diluted)
$-0.22
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASST
ASST
CHYM
CHYM
Q3 25
$255.0K
$543.5M
Q2 25
$173.3K
$528.1M
Q1 25
$170.7K
Q4 24
$212.8K
Q3 24
$421.9M
Q2 24
$93.0K
$384.2M
Q1 24
$124.8K
Q4 23
$80.9K
Net Profit
ASST
ASST
CHYM
CHYM
Q3 25
$-192.3M
$-54.7M
Q2 25
$-8.9M
$-923.4M
Q1 25
$-3.7M
Q4 24
$-4.1M
Q3 24
$-22.0M
Q2 24
$-5.9M
$385.0K
Q1 24
$-4.8M
Q4 23
$-1.3M
Gross Margin
ASST
ASST
CHYM
CHYM
Q3 25
87.2%
Q2 25
87.3%
Q1 25
Q4 24
Q3 24
87.3%
Q2 24
86.9%
Q1 24
Q4 23
Operating Margin
ASST
ASST
CHYM
CHYM
Q3 25
-17288.6%
-11.9%
Q2 25
-1553.9%
-176.2%
Q1 25
-970.5%
Q4 24
-5889.5%
Q3 24
-7.3%
Q2 24
-1857.2%
-2.5%
Q1 24
-1110.9%
Q4 23
-1667.7%
Net Margin
ASST
ASST
CHYM
CHYM
Q3 25
-75406.7%
-10.1%
Q2 25
-5122.4%
-174.8%
Q1 25
-2195.6%
Q4 24
-1935.5%
Q3 24
-5.2%
Q2 24
-6313.1%
0.1%
Q1 24
-3837.7%
Q4 23
-1667.7%
EPS (diluted)
ASST
ASST
CHYM
CHYM
Q3 25
$-0.22
$-0.15
Q2 25
$-0.17
$-7.29
Q1 25
$-0.13
Q4 24
$-5.62
Q3 24
$-0.34
Q2 24
$-0.58
$0.00
Q1 24
$-0.49
Q4 23
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASST
ASST
CHYM
CHYM
Cash + ST InvestmentsLiquidity on hand
$109.1M
$445.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.4M
$1.4B
Total Assets
$792.6M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASST
ASST
CHYM
CHYM
Q3 25
$109.1M
$445.0M
Q2 25
$2.5M
$868.3M
Q1 25
$4.2M
Q4 24
$6.2M
Q3 24
$270.8M
Q2 24
$1.9M
$295.4M
Q1 24
$1.9M
Q4 23
$2.9M
Stockholders' Equity
ASST
ASST
CHYM
CHYM
Q3 25
$779.4M
$1.4B
Q2 25
$10.7M
$1.4B
Q1 25
$19.6M
Q4 24
$23.3M
Q3 24
$-1.9B
Q2 24
$5.4M
$-1.9B
Q1 24
$11.3M
Q4 23
$16.1M
Total Assets
ASST
ASST
CHYM
CHYM
Q3 25
$792.6M
$2.0B
Q2 25
$3.3M
$1.9B
Q1 25
$5.0M
Q4 24
$28.2M
Q3 24
Q2 24
$2.4M
Q1 24
$2.1M
Q4 23
$3.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASST
ASST
CHYM
CHYM
Operating Cash FlowLast quarter
$-14.0M
$17.5M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
0.0%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASST
ASST
CHYM
CHYM
Q3 25
$-14.0M
$17.5M
Q2 25
$-1.7M
Q1 25
$-1.6M
Q4 24
$-6.1M
Q3 24
Q2 24
$-1.3M
Q1 24
$-1.0M
Q4 23
$-854.1K
Free Cash Flow
ASST
ASST
CHYM
CHYM
Q3 25
$15.4M
Q2 25
Q1 25
Q4 24
$-6.2M
Q3 24
Q2 24
$-1.3M
Q1 24
$-1.1M
Q4 23
FCF Margin
ASST
ASST
CHYM
CHYM
Q3 25
2.8%
Q2 25
Q1 25
Q4 24
-2937.1%
Q3 24
Q2 24
-1379.4%
Q1 24
-844.7%
Q4 23
Capex Intensity
ASST
ASST
CHYM
CHYM
Q3 25
0.0%
0.4%
Q2 25
Q1 25
Q4 24
82.7%
Q3 24
Q2 24
3.1%
Q1 24
9.5%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASST
ASST

Segment breakdown not available.

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

Related Comparisons